Referencias
- Allegri RF, Chrem Mendez P, Russo MJ, et al. Biomarkers of Alzheimer's disease in mild cognitive impairment: Experience in a memory clinic from Latin America. Neurologia 2018; Apr 7. pii: S0213-4853(18)30028-8.
- Kwak K, Yun HJ, Park G, Lee JM. Multi-modality sparse representation for Alzheimer's disease classification. J Alzheimers Dis 2018; 65:807-17.
- Frings L, Hellwig S, Bormann T, et al. Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population. Eur J Nucl Med Mol Imaging 2018; 45:1442-8.
- Chételat G. Multimodal neuroimaging in Alzheimer's disease: Early diagnosis, physiopathological mechanisms, and impact of lifestyle. J Alzheimers Dis 2018; 64(s1):S199-S211.
- Lu D, Popuri K, Ding GW, et al. Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer's disease. Alzheimer’s Disease Neuroimaging Initiative. Med Image Anal 2018; 46:26-34.
- Moreland J, Urhemaa T, van Gils M, Lötjönen J, et al. Validation of prognostic biomarker scores for predicting progression of dementia in patients with amnestic mild cognitive impairment. Nucl Med Commun 2018; 39:297-30.
